Sign In
to Vote &
Create Storyboards.
 
(NIH/National Institute of Allergy and Infectious Diseases) NIH has launched a large international study to compare the safety and efficacy of three antiretroviral treatment regimens for pregnant women living with HIV and the safety of these regimens for their infants. The study will evaluate the current preferred first-line regimen for pregnant women recommended by WHO and two regimens containing newer antiretroviral drugs that are becoming more widely used. It will provide data on the use of t...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard